Ginkgetin attenuates bone loss in OVX mice by inhibiting the NF-κB/IκBα signaling pathway
PeerJ · 10.07.2024 · 12 · e17722
DOI: 10.7717/peerj.17722 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, online erschienen am 10.07.2024. Verfasst von GeJin Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, 923rd Hospital of PLA, Nanning, China. Hauptthemen laut MEDLINE: Biflavonoids, Signal Transduction, Osteoporosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
Background
Osteoporosis is a disease associated with bone resorption, characterized primarily by the excessive activation of osteoclasts. Ginkgetin is a compound purified from natural ginkgo leaves which has various biological properties, including anti-inflammation, antioxidant, and anti-tumor effects. This study investigated the bone-protective effects of ginkgetin in ovariectomized (OVX) mice and explored their potential signaling pathway in inhibiting osteoclastogenesis in a mouse model of osteoporosis.
Methods
Biochemical assays were performed to assess the levels of Ca, ALP, and P in the blood. Micro CT scanning was used to evaluate the impact of ginkgetin on bone loss in mice. RT-PCR was employed to detect the expression of osteoclast-related genes (ctsk, c-fos, trap) in their femoral tissue. Hematoxylin and eosin (H&E) staining was utilized to assess the histopathological changes in femoral tissue due to ginkgetin. The TRAP staining was used to evaluate the impact of ginkgetin osteoclast generation in vivo . Western blot analysis was conducted to investigate the effect of ginkgetin on the expression of p-NF-κB p65 and IκBα proteins in mice.
Results
Our findings indicate that ginkgetin may increase the serum levels of ALP and P, while decreasing the serum level of Ca in OVX mice. H&E staining and micro CT scanning results suggest that ginkgetin can inhibit bone loss in OVX mice. The TRAP staining results showed ginkgetin suppresses the generation of osteoclasts in OVX mice. RT-PCR results demonstrate that ginkgetin downregulate the expression of osteoclast-related genes (ctsk, c-fos, trap) in the femoral tissue of mice, and this effect is dose-dependent. Western blot analysis results reveal that ginkgetin can inhibit the expression of p-NF-κB p65 and IκBα proteins in mice.
Conclusion
Ginkgetin can impact osteoclast formation and activation in OVX mice by inhibiting the NF-κB/IκBα signaling pathway, thereby attenuating bone loss in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, 923rd Hospital of PLA, Nanning, China.
- Graduate School, Guilin Medical College, Guilin, China.
Förderung
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
Zitieren
APA
Wei, G., Liang, X., Wu, F., Cheng, C., Huang, S., & Zeng, Y. (2024). Ginkgetin attenuates bone loss in OVX mice by inhibiting the NF-κB/IκBα signaling pathway. PeerJ, 12, e17722. https://doi.org/10.7717/peerj.17722
Vancouver
Wei G, Liang X, Wu F, Cheng C, Huang S, Zeng Y. Ginkgetin attenuates bone loss in OVX mice by inhibiting the NF-κB/IκBα signaling pathway. PeerJ. 2024;12:e17722. doi:10.7717/peerj.17722
BibTeX
@article{Wei2024,
author = {Wei, GeJin and Liang, Xiongbo and Wu, Feng and Cheng, Changzhi and Huang, Shasha and Zeng, Yanping},
title = {Ginkgetin attenuates bone loss in OVX mice by inhibiting the NF-κB/IκBα signaling pathway},
journal = {PeerJ},
year = {2024},
volume = {12},
pages = {e17722},
doi = {10.7717/peerj.17722}
}
EUVIMED